9 earlier Form 4 trades (code P or S) here by this insider (9 sales), the last on Nov 13, 2024.
The trade is 0.7% of the 914,888 shares held after it.
1 other insider sold within 30 days.
74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President Tan Farid sold about $213.2K of MCBS on Nov 25, 2024; 1 other insider sold within 30 days and 74 funds added in the latest 13F quarter.
8 earlier Form 4 trades (code P or S) here by this insider (8 sales), the last on Nov 12, 2024.
The trade is 0.1% of the 920,871 shares held after it.
1 other insider sold within 30 days.
74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President Tan Farid sold about $26.6K of MCBS on Nov 13, 2024; 1 other insider sold within 30 days and 74 funds added in the latest 13F quarter.
7 earlier Form 4 trades (code P or S) here by this insider (7 sales), the last on Nov 11, 2024.
The trade is 0.0% of the 921,620 shares held after it.
1 other insider sold within 30 days.
74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President Tan Farid sold about $14.2K of MCBS on Nov 12, 2024; 1 other insider sold within 30 days and 74 funds added in the latest 13F quarter.
6 earlier Form 4 trades (code P or S) here by this insider (6 sales), the last on Nov 6, 2024.
The trade is 0.2% of the 922,020 shares held after it.
1 other insider sold within 30 days.
74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: President Tan Farid sold about $66.4K of MCBS on Nov 11, 2024; 1 other insider sold within 30 days and 74 funds added in the latest 13F quarter.
2 earlier Form 4 trades (code P or S) here by this insider (2 buys), the last on Mar 13, 2023.
+12.4% median (+12.4% mean) 90-day return after 2 previous buys.
1 other insider sold within 30 days.
74 funds added in the 13F quarter to Jun 30, 2026.
Insider activity: Director Patel Ajit A. sold about $165.5K of MCBS on Nov 7, 2024; 1 other insider sold within 30 days and 74 funds added in the latest 13F quarter.
41 transactions on record
Since filing: total return from the first close after the filing to the latest close, dividend-adjusted. Not a forecast.
Context lines are counts over the filings above and returns from our own price history, never a price level. Not investment advice.
Nobody has filed for crossing 5%. That is a fact, not missing data.
MCBS planned insider sales (Form 144)
No planned-sale notices
No insider has filed to sell. Watch this after a run-up.
MCBS mutual fund holders (N-PORT)
Funds ranked by the share of their own portfolio in this stock (N-PORT).
Regional Bank Fund
$4.1M position · as of 2026-07-31
0.4%
First Trust NASDAQ ABA Community Bank Index Fund
$362.6K position · as of 2026-06-30
0.4%
State Street(R) SPDR(R) US Small Cap Low Volatility Index ETF
$851.0K position · as of 2026-06-30
0.3%
iShares Micro-Cap ETF
$2.8M position · as of 2026-06-30
0.2%
Longboard Fund
$139.2K position · as of 2026-05-31
0.1%
Innovator U.S. Small Cap Managed 10 Buffer ETF
$13.0K position · as of 2026-07-31
0.1%
SEC N-PORT, monthly, about 60 days late · funds ≥ $10M ·
% is the share of the fund's own portfolio
Executive pay vs shareholder return
CEO pay, headline and as actually paid, against the company's
return and its chosen peers' (DEF 14A).
FY
CEO total
Actually paid
Other execs, avg
TSR
Peer TSR
2025
$2.6M
$3.0M
$1.4M
+10%
+15%
2024
$2.3M
$3.1M
$1.2M
+37%
+18%
2023
$2.2M
$2.9M
$2.0M
+15%
+10%
2022
$2.3M
$2.3M
$2.1M
-19%
-12%
Tagged by the company under SEC Item 402(v). Returns are
cumulative from the start of the disclosure period. Green where the company beat its own peer group.
Live price
Daily candles from TradingView, under their licence. No filings marked.
Why this name is on the desk
The complete filing record, in one place.
The record shows 74 funds added last quarter. Each figure is a federal filing, dated the day it went public.
Ratios from the company's XBRL filings, latest filings
Revenue, TTM
n/a
fewer than four consecutive quarters of revenue filed
Revenue, TTM MCBS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Net margin, TTM
n/a
needs four consecutive quarters of both revenue and net income
Net margin, TTM MCBS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Single quarter
Free cash flow, TTM
$81.4M
operating cash flow minus capex, 2025-07-01 to 2026-06-30
Free cash flow, TTM MCBS
FY Dec 2025
$37.0M
FY Dec 2024
$62.2M
FY Dec 2023
$77.2M
FY Dec 2022
$132.3M
FY Dec 2021
$65.0M
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
-$5.4M
Sep 2025
$16.2M
Jun 2025
$14.3M
Mar 2025
$11.8M
Dec 2024
$18.9M
Sep 2024
-$11.8M
At each fiscal year end
Single quarter
Debt to equity
n/a
no debt line filed
Debt to equity MCBS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Cash flow to debt
n/a
no debt line filed
Cash flow to debt MCBS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on equity
+15.9%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on equity MCBS
FY Dec 2025
+14.2%
FY Dec 2024
+16.1%
FY Dec 2023
+14.1%
FY Dec 2022
+19.6%
FY Dec 2021
+23.1%
Jun 2026
+15.9%
Mar 2026
+15.2%
Dec 2025
+14.2%
Sep 2025
+15.6%
Jun 2025
+15.7%
Mar 2025
+16.0%
Dec 2024
+16.1%
Sep 2024
+15.1%
At each fiscal year end
Trailing four quarters at each quarter end
Return on assets
+2.0%
TTM net income over average of 2025-06-30 and 2026-06-30
Return on assets MCBS
FY Dec 2025
+1.6%
FY Dec 2024
+1.8%
FY Dec 2023
+1.5%
FY Dec 2022
+1.9%
FY Dec 2021
+2.5%
Jun 2026
+2.0%
Mar 2026
+1.8%
Dec 2025
+1.6%
Sep 2025
+1.9%
Jun 2025
+1.8%
Mar 2025
+1.8%
Dec 2024
+1.8%
Sep 2024
+1.7%
At each fiscal year end
Trailing four quarters at each quarter end
Return on invested capital
n/a
fewer than four consecutive quarters of operating income
Return on invested capital MCBS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
Return on capital employed
n/a
fewer than four consecutive quarters of operating income
Return on capital employed MCBS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
P/E, trailing
12.63x
close 2026-10-26 over four quarters of diluted EPS, 2025-07-01 to 2026-06-30
P/E, trailing MCBS
FY Dec 2025
10.09x
FY Dec 2024
12.73x
FY Dec 2023
11.89x
FY Dec 2022
8.83x
FY Dec 2021
11.47x
Jun 2026
12.46x
Mar 2026
10.35x
Dec 2025
10.09x
Sep 2025
10.73x
Jun 2025
11.16x
Mar 2025
10.73x
Dec 2024
12.73x
Sep 2024
13.20x
At each fiscal year end
Trailing four quarters at each quarter end
Enterprise value
n/a
no debt line filed
Enterprise value MCBS
FY Dec 2025
n/a
FY Dec 2024
n/a
FY Dec 2023
n/a
FY Dec 2022
n/a
FY Dec 2021
n/a
Jun 2026
n/a
Mar 2026
n/a
Dec 2025
n/a
Sep 2025
n/a
Jun 2025
n/a
Mar 2025
n/a
Dec 2024
n/a
Sep 2024
n/a
At each fiscal year end
Trailing four quarters at each quarter end
FCF yield
+7.8%
TTM free cash flow over market value at close 2026-10-26
FCF yield MCBS
FY Dec 2025
+5.5%
FY Dec 2024
+7.7%
FY Dec 2023
+12.7%
FY Dec 2022
+24.2%
FY Dec 2021
+9.3%
Jun 2026
+7.9%
Mar 2026
+8.6%
Dec 2025
+5.5%
Sep 2025
+8.7%
Jun 2025
+4.6%
Mar 2025
+5.4%
Dec 2024
+7.7%
Sep 2024
+4.4%
At each fiscal year end
Trailing four quarters at each quarter end
PEG, trailing
1.01x
P/E over trailing EPS growth of 13%: four quarters to 2026-06-30 against the four to 2025-06-30
PEG, trailing MCBS
FY Dec 2025
2.11x
FY Dec 2024
0.52x
FY Dec 2023
n/a
FY Dec 2022
4.24x
FY Dec 2021
0.16x
Jun 2026
1.00x
Mar 2026
1.33x
Dec 2025
2.11x
Sep 2025
0.96x
Jun 2025
0.54x
Mar 2025
0.35x
Dec 2024
0.52x
Sep 2024
0.77x
At each fiscal year end
Trailing four quarters at each quarter end
Price as of 2026-10-26. Hover or tap a tile for its yearly and quarterly history.Method
TTM is four consecutive fiscal quarters; Q4 is the year minus nine months when not filed. Returns use the average of opening and closing balances. EBIT is approximated by operating income. PEG uses trailing EPS growth.
Fundamentals
Annual figures from XBRL filings. Pick a past date to see them as known then.
MCBS ranks highest on profitability (93rd percentile) and risk and compliance (42nd), and lowest on institutional and government (37th), among Banks peers.
Profitability
93
Inputs
Return on equity+15.9% · 91 pct, sector of 327
Return on assets+2.0% · 95 pct, sector of 334
Return on invested capitalfewer than four consecutive quarters of operating income
Return on capital employedfewer than four consecutive quarters of operating income
Institutional and government
37
Inputs
Funds adding, latest quarter74 · 37 pct, sector of 257
Congress net buyers, 365dno Congress trades in 365 days
Federal contracts, 180dno federal contracts in 180 days
Lobbying spend, 4 quartersno lobbying filings in the last four quarters
Risk and compliance
42
Inputs
Short interest, % of float+3.8% · 42 pct, sector of 378
Recalls per $1B revenue, 3yrevenue under $50M or not filed, so a count cannot be scaled to size
EPA cases per $1B revenue, 5yrevenue under $50M or not filed, so a count cannot be scaled to size
New text in Risk Factors, latest 10-Kneeds two 10-Ks with a Risk Factors section (not 20-F filers or stubs)
4 not measured: Financial health, Growth, Insider conviction, US patents
Financial health needs 1 of 2 inputs, 0 present: no debt line filed
Growth needs 1 of 2 inputs, 0 present: no backlog line filed, or no year-earlier backlog; no revenue for this year and the year before
Insider conviction needs 1 of 2 inputs, 0 present: no Form 4 purchase or sale (code P or S) in 180 days; no insider trades in 180 days
US patents needs 1 of 2 inputs, 0 present: patent data not loaded yet
3 of 7 axes scored. Each is a percentile against sector peers (all companies when the sector is thin); higher is better. An unscored axis is unmeasured, not low. How it is scored
Explore insider trading and ownership data
Every company we track, ranked by each kind of filing
No password to create and no card required. We store your email address, your watchlist and your preferences, nothing else.
PRIVACY & COOKIES
We track filings, not you.
Essential cookies keep you signed in and remember this choice.
Google Analytics 4 and Microsoft Clarity load only if you allow them here; they
count visits and record how pages are used. We run no advertising and never sell
data. Details in the privacy policy. Change this any time
via "Cookie settings" in the footer.